Cti Biopharma reported $-15705000 in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Baxter International BAX:US USD -2937000000 3.19B
Bristol Myers Squibb BMY:US USD 1.61B 185M
Cti Biopharma CTIC:US USD -15705000 6.95M
Cytori Therapeutics CYTX:US USD -5219000 63K
Eli Lilly And LLY:US USD 1.45B 499.2M
Mirati Therapeutics MRTX:US USD -173561000 2.88M
Northwest Biotherapeutics NWBO:US USD -32852000 3.18M
Novartis NVS:US USD 1.57B 121M
Novartis NOVN:VX USD 1.57B 121M
Seattle Genetics SGEN:US USD -190816000 55.99M
Teva Pharmaceutical Industries TEVA:US USD 55M 288M
YTE INCY:US USD 112.78M 48.66M